Across TCGA pan-cancer cohorts, EIF4A2P4 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of EIF4A2P4’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EIF4A2P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF4A2P4 is over-expressed in tumor, although a few such as UCEC and BRCA show the opposite, repressed pattern.

COAD, UCEC, and BRCA are the cancer types where EIF4A2P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIF4A2P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.601	<.001	8	view →
UCEC	All	IV	−1.150	.005	4	view →
BRCA	Female	All	−0.060	.019	2	view →
STAD	All	All	−0.217	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: EIF4A2P4 RNA expression & survival · all EIF4A2P4 data types